Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
TempraMed Technologies Ltd. ( (TSE:VIVI) ) has provided an announcement.
TempraMed Technologies Ltd. has announced the opening of a new manufacturing facility in Florida to expand its U.S. production capacity and meet rising demand for its temperature-sensitive medication storage devices. This development enhances operational scalability, reduces costs through localized production, and improves logistics efficiency, positioning the company to better serve healthcare providers, pharmacies, and global B2B customers while driving growth in the temperature-sensitive medication industry.
More about TempraMed Technologies Ltd.
TempraMed Technologies Ltd. is a leading global provider of temperature-controlled medication storage solutions, specializing in patented, FDA-registered devices that use space-grade thermal insulation to maintain medication efficacy without the need for batteries or external power. Headquartered in Israel, with operations across North America, Europe, and Asia, the company’s mission is to protect temperature-sensitive medications for healthcare providers and patients worldwide.
Average Trading Volume: 15,083
For an in-depth examination of VIVI stock, go to TipRanks’ Overview page.